Question explored with the scientific record
Could the Covid mRNA vaccines have caused my stroke and brain abscess
The short version: a plausible mechanism exists, but the evidence for a direct link between the mRNA vaccine and your specific outcomes—stroke and brain abscess—is thin and circumstantial.
The evidence you have is a collection of case reports and reviews that show the mRNA vaccines can trigger serious clotting and autoimmune events. One case report describes a 22-year-old healthy male who developed antiphospholipid syndrome (APS) with a large pulmonary embolus after his second mRNA dose [2, 4]. APS is a condition where the immune system attacks clotting proteins, making the blood hypercoagulable—it clots too easily. Another case report describes a 28-year-old man who developed vaccine-induced immune thrombotic thrombocytopenia (VITT) after a booster, with severe clotting and a platelet count of 34 (normal is 143-349) [7]. A third case report describes a 34-year-old man who died from an aortic dissection 16 days after his first dose, with autopsy showing vaccine-derived spike protein in the tissue [6]. These are not common events, but they are documented.
A stroke is a clot or bleed in the brain. A brain abscess is a pocket of infection. The mechanism that connects the vaccine to a stroke is plausible: if the vaccine triggers APS or VITT, a clot could form and travel to the brain. The evidence for a brain abscess is weaker. The vaccine is not known to directly cause bacterial infections. An abscess usually follows a separate event—a dental infection, sinusitis, or a procedure that lets bacteria into the brain. If the vaccine caused a stroke that then became infected, that is a two-step chain, not a direct effect. The evidence does not include a single case of brain abscess after mRNA vaccination.
The evidence here is all case reports and narrative reviews. There are no large controlled studies comparing stroke or brain abscess rates in vaccinated versus unvaccinated people. The studies that do exist focus on myocarditis, not neurological events [1, 3, 5]. The absence of a large safety study with neurological endpoints is a gap, not proof of safety. But the gap also means the link between the vaccine and your specific outcomes is not established.
| Condition | Evidence in retrieved studies | Strength of link |
|---|---|---|
| Stroke (clot) | Plausible via APS or VITT; case reports of clotting events [2, 4, 7] | Moderate plausibility, low population evidence |
| Brain abscess | No cases reported; no known direct mechanism | Very low plausibility |
My call: the vaccine could have contributed to a clotting event that led to a stroke, but the evidence for a brain abscess is absent. Confidence: low for stroke, very low for brain abscess.
Sources used 7
-
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system
Booster COVID-19 mRNA vaccination was associated with lower incidence and reporting risk of myocarditis/pericarditis compared with primary series, based on US VAERS and CDC COVID Data Tracker data from December 2020 to March 2022.
DOI: 10.3389/fimmu.2022.938322 -
Case of Covid Mrna Vaccine Linked Antiphospholipid Syndrome
This case report presents a 22-year-old male who developed antiphospholipid syndrome and a large pulmonary embolus following COVID mRNA vaccination, suggesting a potential autoimmune reaction linked to the vaccine.
DOI: 10.33140/ijdmd.07.01.07 -
Myocarditis With COVID-19 mRNA Vaccines
This narrative review characterizes myocarditis/pericarditis as a rare complication of COVID-19 mRNA vaccination, particularly in young males after the second dose, with a generally self-limited course and a favorable overall benefit-risk balance supporting universal vaccination.
DOI: 10.1161/circulationaha.121.056135 -
A Case of COVID mRNA Vaccine Linked Antiphospholipid Syndrome
A 22-year-old healthy male developed antiphospholipid syndrome with a large pulmonary embolus, markedly elevated triple-positive antiphospholipid antibodies, and multisystem symptoms after his second dose of an mRNA COVID vaccine, with negative COVID testing, and improved on api…
DOI: 10.33140/bscr.02.01.13 -
The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis
COVID-19 mRNA vaccination clearly outweighs the rare risk of myocarditis and pericarditis; incidence is about 1-4 per 100,000, mainly in young males after the second dose, and COVID-19 itself poses a much larger myocarditis risk.
DOI: 10.1007/s12471-022-01677-9 -
Case of Myocarditis, Pericarditis, and Fatal Aortic Dissection Following COVID-19 mRNA Vaccination
A 34-year-old previously healthy male developed myocarditis, pericarditis, and a fatal thoracic aortic dissection 16 days after his first COVID-19 mRNA vaccine dose, with autopsy showing vaccine-derived spike protein and eosinophilic/lymphocytic infiltrates.
DOI: 10.33140/bscr.03.03.03 -
Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report
This case report describes a previously healthy 28-year-old man who developed vaccine-induced immune thrombotic thrombocytopenia (VITT) following his third dose of the BNT162b2 mRNA COVID-19 vaccine, presenting with severe thrombotic events and responding well to intravenous imm…
DOI: 10.3390/vaccines11061115